ALI HEALTH
00241
JD HEALTH
06618
XIAOMI-W
01810
4
KUAISHOU-W
01024
5
BABA-W
09988
(FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | (FY)Jun 30, 2020 | (Q6)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -29.24%4.77B | ---- | -7.83%6.74B | ---- | -43.76%7.31B | ---- | 491.18%13.01B | ---- | -71.50%2.2B | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -66.67%-80M | ---- | 19.50%-48M | ---- | 11.69%-59.63M | ---- | 3.50%-67.52M | ---- | -14.64%-69.97M | ---- |
Dividend (income)- adjustment | -68.42%-64M | ---- | -42.00%-38M | ---- | -34.98%-26.76M | ---- | 39.64%-19.83M | ---- | 31.99%-32.85M | ---- |
Attributable subsidiary (profit) loss | 31.07%-639M | ---- | -183.13%-927M | ---- | 16.32%-327.41M | ---- | 10.72%-391.25M | ---- | 72.52%-438.22M | ---- |
Impairment and provisions: | 4,675.00%764M | ---- | 72.99%16M | ---- | -98.23%9.25M | ---- | 3,395.52%523.47M | ---- | 418.44%14.98M | ---- |
-Impairment of property, plant and equipment (reversal) | --748M | ---- | ---- | ---- | ---- | ---- | --480.76M | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | 0.00%16M | ---- | 72.99%16M | ---- | -78.34%9.25M | ---- | 185.20%42.71M | ---- | 418.44%14.98M | ---- |
Revaluation surplus: | 209.24%201M | ---- | -128.19%-184M | ---- | 18.09%652.72M | ---- | -72.69%552.71M | ---- | 202.90%2.02B | ---- |
-Fair value of investment properties (increase) | 207.82%193M | ---- | -126.20%-179M | ---- | 23.26%683.17M | ---- | -72.57%554.23M | ---- | 202.81%2.02B | ---- |
-Other fair value changes | 260.00%8M | ---- | 83.58%-5M | ---- | -1,898.27%-30.45M | ---- | -150.59%-1.52M | ---- | 348.02%3.01M | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | 77.02%-4.08M | ---- | 90.11%-17.74M | ---- | -42.68%-179.39M | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16.51%-41.62M | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | 84.42%-74.08K | ---- | -365.05%-475.48K | ---- | -108.75%-102.24K | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | 76.82%-4M | ---- | 87.46%-17.27M | ---- | -78.68%-137.66M | ---- |
Depreciation and amortization: | -20.40%160M | ---- | 11.04%201M | ---- | -2.76%181.02M | ---- | 0.32%186.15M | ---- | 30.19%185.55M | ---- |
-Other depreciation and amortization | ---- | ---- | --3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Financial expense | 4.88%43M | ---- | 31.51%41M | ---- | -33.20%31.18M | ---- | 56.45%46.67M | ---- | -50.39%29.83M | ---- |
Special items | -68.22%-2.34B | ---- | -312.44%-1.39B | ---- | 41.06%-337.26M | ---- | 44.19%-572.16M | ---- | -59.38%-1.03B | ---- |
Operating profit before the change of operating capital | -36.18%2.82B | ---- | -40.66%4.41B | ---- | -43.89%7.43B | ---- | 389.05%13.25B | ---- | -22.27%2.71B | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -37.15%2.76B | ---- | -18.22%4.39B | ---- | 2,062.68%5.37B | ---- | -154.31%-273.38M | ---- | -67.35%503.33M | ---- |
Developing property (increase)decrease | 33.50%-2.91B | ---- | -68.45%-4.38B | ---- | -134.81%-2.6B | ---- | 304.10%7.47B | ---- | -48.85%-3.66B | ---- |
Accounts receivable (increase)decrease | 149.81%256M | ---- | -39.36%-514M | ---- | -125.07%-368.83M | ---- | 61.44%-163.87M | ---- | -384.57%-425.03M | ---- |
Accounts payable increase (decrease) | -7.58%-298M | ---- | -227.81%-277M | ---- | 46.59%216.74M | ---- | 623.33%147.85M | ---- | 102.10%20.44M | ---- |
Special items for working capital changes | 59.41%-714M | ---- | 46.15%-1.76B | ---- | 81.44%-3.27B | ---- | -342.93%-17.6B | ---- | -49.89%7.25B | ---- |
Cash from business operations | 1.87%1.91B | ---- | -72.42%1.87B | ---- | 140.16%6.78B | ---- | -55.84%2.82B | ---- | -59.96%6.39B | ---- |
Hong Kong profits tax paid | 66.77%-825M | ---- | -635.61%-2.48B | ---- | 30.06%-337.54M | ---- | -11.43%-482.62M | ---- | 39.20%-433.1M | ---- |
Other taxs | -56.25%-75M | ---- | 21.00%-48M | ---- | 70.63%-60.76M | ---- | -26.19%-206.84M | ---- | 84.97%-163.91M | ---- |
Dividend received - operating | 68.42%64M | ---- | 59.19%38M | ---- | 41.23%23.87M | ---- | -36.31%16.9M | ---- | 55.64%26.54M | ---- |
Interest received - operating | 66.67%80M | ---- | -19.50%48M | ---- | -11.69%59.63M | ---- | -3.50%67.52M | ---- | 14.64%69.97M | ---- |
Special items of business | ---- | -15.82%1.54B | ---- | -56.48%1.83B | ---- | 1,942.91%4.21B | ---- | -96.25%205.86M | ---- | 15,030.93%5.48B |
Net cash from operations | 299.83%1.15B | -15.82%1.54B | -108.89%-575M | -56.48%1.83B | 191.47%6.47B | 1,942.91%4.21B | -62.36%2.22B | -96.25%205.86M | -58.63%5.89B | 15,030.93%5.48B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 133.02%1.98B | 438.16%962.44M | 112.08%851M | --178.84M | -11.06%401.25M | ---- | -59.40%451.17M | ---- | 142.57%1.11B | ---- |
Dividend received - investment | -37.19%846M | -76.99%228.5M | 159.22%1.35B | 3,303.79%993.05M | -63.24%519.63M | -87.85%29.18M | -44.48%1.41B | -81.60%240.08M | 321.66%2.55B | 631.20%1.3B |
Loan receivable (increase) decrease | 1,438.24%455M | 120.74%253.14M | -122.25%-34M | -20.32%-1.22B | 107.42%152.78M | 31.45%-1.01B | 11.37%-2.06B | 51.34%-1.48B | -618.39%-2.32B | -194.66%-3.04B |
Decrease in deposits (increase) | -219.35%-9.59B | 69.22%-2.74B | 74.14%-3B | -110.99%-8.89B | -330.94%-11.61B | 52.23%-4.21B | 145.14%5.03B | -176.63%-8.82B | 125.43%2.05B | 316.82%11.51B |
Sale of fixed assets | -66.67%1M | ---- | 1,669.40%3M | ---- | -72.22%169.55K | ---- | 72.90%610.3K | ---- | -24.61%352.98K | ---- |
Purchase of fixed assets | 36.11%-69M | -96.14%-29.89M | -105.77%-108M | 45.87%-15.24M | -38.16%-52.48M | -22.40%-28.15M | 21.51%-37.99M | -11.68%-23M | 26.98%-48.4M | 30.60%-20.6M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 213.81%346.58M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | 100.00%-13.19K | ---582.5M | -2,796.52%-450M | ---- | 98.59%-15.54M | 98.59%-15.54M |
Recovery of cash from investments | -66.67%1M | -68.94%800K | -97.06%3M | 1.11%2.58M | 38.61%101.97M | -95.61%2.55M | -67.92%73.57M | -70.97%58.02M | 0.00%229.35M | 54.66%199.88M |
Cash on investment | 41.81%-483M | 20.74%-1.01B | -5.76%-830M | -720.45%-1.27B | -321.61%-784.77M | 69.22%-155.07M | 73.94%-186.13M | -277.74%-503.75M | -278.53%-714.13M | -90.34%-133.36M |
Other items in the investment business | ---- | 9.86%166.04K | ---- | -99.95%151.13K | 508.00%76M | -13.24%304.32M | 149.54%12.5M | -35.80%350.76M | ---25.23M | 158.59%546.35M |
Net cash from investment operations | -287.13%-6.86B | 77.21%-2.33B | 84.18%-1.77B | -80.69%-10.22B | -363.76%-11.2B | 44.41%-5.66B | 34.46%4.25B | -198.33%-10.17B | 141.71%3.16B | 472.82%10.35B |
Net cash before financing | -143.27%-5.71B | 90.60%-788.45M | 50.41%-2.35B | -478.42%-8.39B | -173.20%-4.73B | 85.45%-1.45B | -28.58%6.46B | -162.97%-9.97B | 35.60%9.05B | 662.93%15.83B |
Cash flow from financing activities | ||||||||||
New borrowing | 11.15%1.05B | 80.67%173.55M | 304.60%942M | -14.73%96.06M | -78.23%232.82M | -38.74%112.65M | -23.48%1.07B | -55.72%183.88M | -62.36%1.4B | -84.73%415.28M |
Refund | 21.00%-1.32B | -212.20%-1.2B | 24.31%-1.67B | 80.98%-382.84M | -39.60%-2.2B | -1,749.73%-2.01B | 30.16%-1.58B | 89.26%-108.84M | -223.20%-2.26B | -347.70%-1.01B |
Interest paid - financing | 46.09%-62M | 25.69%-36.98M | -159.75%-115M | -141.35%-49.76M | 28.69%-44.27M | 37.89%-20.62M | 46.95%-62.09M | 46.99%-33.2M | -19.06%-117.04M | -57.09%-62.63M |
Dividends paid - financing | -97.88%-1.03B | -86.21%-690.29M | 87.34%-519M | 87.30%-370.7M | -671.61%-4.1B | -995.21%-2.92B | 59.10%-531.44M | 76.39%-266.47M | -43.59%-1.3B | -60.64%-1.13B |
Other items of the financing business | ---- | ---- | ---- | 53.15%-7.15K | ---- | -69.61%-15.27K | ---- | 87.66%-9K | ---- | 78.74%-72.94K |
Net cash from financing operations | 0.57%-1.4B | -140.61%-1.77B | 77.13%-1.41B | 84.88%-736.13M | -433.73%-6.17B | -1,833.56%-4.87B | 50.38%-1.16B | 86.12%-251.77M | -215.82%-2.33B | -203.68%-1.81B |
Effect of rate | 104.08%4M | 126.29%21.67M | -63.32%-98M | -325.40%-82.44M | -131.52%-60.01M | -78.79%36.58M | 339.44%190.35M | 586.47%172.41M | -14.13%-79.5M | 44.11%-35.44M |
Net Cash | -89.25%-7.11B | 71.95%-2.56B | 65.54%-3.76B | -44.43%-9.13B | -305.39%-10.9B | 38.18%-6.32B | -21.03%5.31B | -172.92%-10.22B | -22.62%6.72B | 1,419.77%14.02B |
Begining period cash | -21.88%13.76B | -21.88%13.76B | -38.35%17.62B | -38.35%17.62B | 23.82%28.58B | 23.82%28.58B | 40.40%23.08B | 40.40%23.08B | 110.13%16.44B | 110.13%16.44B |
Items Period | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.46M |
Cash at the end | -51.63%6.66B | 33.48%11.22B | -21.88%13.76B | -62.28%8.41B | -38.35%17.62B | 71.08%22.3B | 23.82%28.58B | -57.15%13.03B | 40.40%23.08B | 354.11%30.42B |
Cash balance analysis | ||||||||||
Cash and bank balance | 5.66%46.42B | -0.75%44.13B | --43.93B | 5.70%44.46B | ---- | -0.87%42.06B | 1.08%44.13B | 2.13%42.43B | 11.75%43.66B | 56.34%41.55B |
Bank deposits | -35.30%1.81B | -24.36%2.54B | --2.79B | -12.00%3.35B | ---- | -14.64%3.81B | ---- | -53.22%4.47B | -47.23%6.02B | 144.76%9.55B |
Cash and cash equivalent balance | 3.21%48.22B | -2.40%46.67B | --46.73B | 4.23%47.82B | ---- | -2.18%45.88B | -11.17%44.13B | -8.21%46.9B | -1.58%49.68B | 67.65%51.09B |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | KPMG | -- | KPMG | -- | KPMG | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.